These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25804871)

  • 1. Local immunotherapy via delivery of interleukin-10 and transforming growth factor β antagonist for treatment of chronic kidney disease.
    Rodell CB; Rai R; Faubel S; Burdick JA; Soranno DE
    J Control Release; 2015 May; 206():131-9. PubMed ID: 25804871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.
    Soranno DE; Rodell CB; Altmann C; Duplantis J; Andres-Hernando A; Burdick JA; Faubel S
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F362-72. PubMed ID: 26962109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy with injectable hydrogels to treat obstructive nephropathy.
    Soranno DE; Lu HD; Weber HM; Rai R; Burdick JA
    J Biomed Mater Res A; 2014 Jul; 102(7):2173-80. PubMed ID: 23913854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
    Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A self-assembling peptide hydrogel-based drug co-delivery platform to improve tissue repair after ischemia-reperfusion injury.
    Liu S; Zhao M; Zhou Y; Li L; Wang C; Yuan Y; Li L; Liao G; Bresette W; Chen Y; Cheng J; Lu Y; Liu J
    Acta Biomater; 2020 Feb; 103():102-114. PubMed ID: 31843715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
    Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
    FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice.
    Shamskhou EA; Kratochvil MJ; Orcholski ME; Nagy N; Kaber G; Steen E; Balaji S; Yuan K; Keswani S; Danielson B; Gao M; Medina C; Nathan A; Chakraborty A; Bollyky PL; De Jesus Perez VA
    Biomaterials; 2019 May; 203():52-62. PubMed ID: 30852423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
    Efrati S; Berman S; Chachashvili A; Cohen N; Siman-Tov Y; Averbukh Z; Weissgarten J
    Nephrology (Carlton); 2009 Apr; 14(2):189-97. PubMed ID: 19143945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel injectable thermosensitive hydrogels for delivering hyaluronic acid-doxorubicin nanocomplexes to locally treat tumors.
    Jhan HJ; Liu JJ; Chen YC; Liu DZ; Sheu MT; Ho HO
    Nanomedicine (Lond); 2015; 10(8):1263-74. PubMed ID: 25479463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.
    Peattie RA; Rieke ER; Hewett EM; Fisher RJ; Shu XZ; Prestwich GD
    Biomaterials; 2006 Mar; 27(9):1868-75. PubMed ID: 16246413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels.
    Rodell CB; Kaminski AL; Burdick JA
    Biomacromolecules; 2013 Nov; 14(11):4125-34. PubMed ID: 24070551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.
    Widjaja LK; Bora M; Chan PN; Lipik V; Wong TT; Venkatraman SS
    J Biomed Mater Res A; 2014 Sep; 102(9):3056-65. PubMed ID: 24124098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
    Matsui M; Tabata Y
    Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis.
    Qin X; Xu Y; Zhou X; Gong T; Zhang ZR; Fu Y
    Acta Pharm Sin B; 2021 Mar; 11(3):835-847. PubMed ID: 33777685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evaluation of primary renal cell/biomaterial neo-kidney augment prototypes for renal tissue engineering.
    Basu J; Genheimer CW; Rivera EA; Payne R; Mihalko K; Guthrie K; Bruce AT; Robbins N; McCoy D; Sangha N; Ilagan R; Knight T; Spencer T; Wagner BJ; Jayo MJ; Jain D; Ludlow JW; Halberstadt C
    Cell Transplant; 2011; 20(11-12):1771-90. PubMed ID: 21439130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
    Jung KJ; Kim J; Park YK; Yoon YR; Park KM
    Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.
    Conway TF; Hammer L; Furtado S; Mathiowitz E; Nicoletti F; Mangano K; Egilmez NK; Auci DL
    J Crohns Colitis; 2015 Aug; 9(8):647-58. PubMed ID: 25987350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An injectable drug delivery platform for sustained combination therapy.
    Baumann MD; Kang CE; Stanwick JC; Wang Y; Kim H; Lapitsky Y; Shoichet MS
    J Control Release; 2009 Sep; 138(3):205-13. PubMed ID: 19442692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatically cross-linked hyaluronic acid/graphene oxide nanocomposite hydrogel with pH-responsive release.
    Song F; Hu W; Xiao L; Cao Z; Li X; Zhang C; Liao L; Liu L
    J Biomater Sci Polym Ed; 2015; 26(6):339-52. PubMed ID: 25598448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.